Mahesan Subramaniam: Reversing Age-Related Decline in Blood Stem Cells
Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn about a recent article by Tasleem Arif et al, published in Cell Press:
“Scientists have uncovered a promising way to reverse age related decline in blood stem cells, at least in animal models. These cells live deep inside the bone marrow and are responsible for constantly producing new blood and immune cells.
As the body ages, blood stem cells gradually lose their balance.
They become less efficient, more stressed, and biased toward producing certain cell types, which contributes to weaker immunity, slower recovery, and higher risk of blood disorders in older age.
The key discovery centers on lysosomes, the tiny recycling units inside cells. In young blood stem cells, lysosomes carefully manage waste removal and energy balance.
With aging, these lysosomes become overly acidic and overactive, which disrupts the internal environment of the cell instead of helping it.
Researchers found that by gently calming this lysosomal activity in old mouse stem cells, the cells regained a healthier internal state.
When these treated cells were returned to the animals, they began producing blood cells more efficiently and behaved much more like youthful stem cells.
This does not mean aging can be reversed in people yet, but it shows that decline in blood stem cells is not permanent.
By targeting internal cleanup and energy systems rather than replacing cells entirely, scientists see potential for future treatments that strengthen immunity, improve blood health, and enhance stem cell therapies as people age.”
Title: Reversing lysosomal dysfunction restores youthful state in aged hematopoietic stem cells
Authors: Tasleem Arif, Jiajing Qiu, Hossein Khademian, Anusree Lohithakshan, Anagha Menon, Vijay Menon, Mary Slavinsky, Maxime Batignes, Miao Lin, Robert Sebra, Kristin G Beaumont, Deanna L Benson, Nikolaos Tzavaras, Mickaël M Ménager, Saghi Ghaffari
Read the Full Article on Cell Press.
Find more posts featuring Mahesan Subramaniam on Hemostasis Today.
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 24, 2026, 00:41Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders